NOVNEENovartis AG
128.28CHF-0.67%Mkt Cap: 284.58B $P/E: 22.79

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to tre…

Indicators:|

Key Statistics

Company
Market Cap284.58B $
Enterprise Value322.60B $
Revenue (TTM)64.57B $
Gross Profit49.05B $
Net Income (TTM)15.96B $
Revenue/Share33.56 USD
Last Price128.28 CHF
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees75.3K
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - General
ISINCH0012005267
Valuation
P/E (Trailing)22.79
P/E (Forward)
PEG
EV/EBITDA12.33
EV/Revenue5.00
P/S4.36
P/B7.89
EPS (TTM)5.63
EPS (Forward)
52W Range
108.8495% of range129.40
52W High129.40 CHF
52W Low108.84 CHF
Profitability
Gross Margin75.83%
Oper. Margin30.48%
EBITDA Margin40.51%
Profit Margin24.67%
ROE30.31%
ROA12.60%
Growth
Revenue Growth-0.70%
Earnings Growth-9.30%
Cash Flow & Leverage
Operating CF21.85B $
CapEx (TTM)4.45B $
FCF Margin21.25%
FCF Yield4.82%
Net Debt45.77B $
Net Debt/EBITDA1.75
Balance Sheet
Debt/Equity0.77
Current Ratio0.85
Quick Ratio0.53
Book Value/Sh16.09 CHF
Cash/Share3.612 CHF
Dividends
Fwd Div Rate
Trail. Div Rate4.666 CHF
Div. Yield
5Y Avg Yield
Payout Ratio
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.0
Float1.81B
Insiders
Institutions
Technical
SMA 50118.05 (+8.7%)
SMA 200118.64 (+8.1%)
Beta0.49
S&P 52W Chg20.05%
Avg Vol (30d)130.25K
Avg Vol (10d)130.00K
Technical Indicators
RSI (14)66.9
MACD2.5762
MACD Signal1.9778
MACD Hist.+0.5984
BB Upper130.06 CHF
BB Middle122.82 CHF
BB Lower115.59 CHF
BB Width11.78%
ATR (14)2.302 CHF
Vol Ratio (20d)1.00x